GO:0043517 positive regulation of DNA damage response, signal transduction by p53 class mediator: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043517 describes any process that activates, maintains, or increases the rate of the p53-mediated DNA damage response signaling cascade.
• The term is a biological process centered on the tumor suppressor p53 (TP53) and its upstream regulators and downstream effectors.
• Key genes include TP53, ATM, ATR, CHEK1, CHEK2, MDM2, and CDKN1A, which coordinate cell cycle arrest, DNA repair, or apoptosis.
• Dysregulation of this pathway is linked to cancer, neurodegeneration, and premature aging disorders.
• Experimental models such as CRISPR knockout, point mutation, and knock-in cell lines are essential to dissect the pathway.
• EDITGENE provides custom CRISPR cell models and library screening to study GO:0043517 in a publication-ready manner.
Description
The Gene Ontology (GO) term GO:0043517, positive regulation of DNA damage response, signal transduction by p53 class mediator, defines a biological process that enhances the p53-dependent signaling cascade triggered by DNA damage. This term captures the regulatory inputs that amplify or sustain p53 activation, leading to cell cycle arrest, DNA repair, senescence, or apoptosis. Understanding this process is critical because p53 is one of the most frequently mutated tumor suppressors in human cancers, and its regulatory network is a major focus of cancer biology and drug discovery. Researchers studying GO:0043517 aim to identify the molecular players that modulate p53 activity and to develop experimental models that faithfully recapitulate human disease. The pathway is highly conserved and involves a complex interplay of kinases, phosphatases, ubiquitin ligases, and transcriptional cofactors. This article provides a research-grade overview of the term, its definition, key genes, mechanisms, disease relevance, and state-of-the-art methods for its study.
positive regulation of DNA damage response, signal transduction by p53 class mediator At A Glance
| GO ID | GO:0043517 |
|---|---|
| GO term | positive regulation of DNA damage response, signal transduction by p53 class mediator |
| Ontology | biological_process |
| Synonym | activation of DNA damage response, signal transduction by p53 class mediator; positive regulation of p53 induced by DNA damage response; stimulation of DNA damage response, signal transduction by p53 class mediator; up regulation of DNA damage response, signal transduction by p53 class mediator; up-regulation of DNA damage response, signal transduction by p53 class mediator; upregulation of DNA damage response, signal transduction by p53 class mediator |
| Major function | Enhances p53-mediated signaling in response to DNA damage, leading to cell cycle arrest, DNA repair, senescence, or apoptosis. |
| Related GO terms | positive regulation of signal transduction by p53 class mediator; DNA damage response, signal transduction by p53 class mediator; regulation of DNA damage response, signal transduction by p53 class mediator. |
| Key regulators | ATM, ATR, CHEK1, CHEK2, MDM2, MDM4, ARF, and others. |
| Disease relevance | Cancer, neurodegeneration, and premature aging syndromes. |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, RNA-seq, proteomics, and imaging. |
What Is GO:0043517?
GO:0043517 is defined as any process that activates, maintains, or increases the rate of the cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage. In simpler terms, it is the positive regulation of the p53-mediated DNA damage response signaling pathway. This term is a child of positive regulation of signal transduction by p53 class mediator and is part of the broader DNA damage response.
Why Is positive regulation of DNA damage response, signal transduction by p53 class mediator Important in Cell Biology?
GO:0043517 is important because the p53 pathway is a central hub for maintaining genomic integrity and preventing tumorigenesis. Positive regulation of this pathway ensures that cells respond appropriately to DNA damage, and its dysregulation can lead to cancer, neurodegeneration, or accelerated aging. Understanding the positive regulators of p53 signaling provides insights into disease mechanisms and identifies potential therapeutic targets.
• p53 is mutated in over 50% of human cancers, making its regulatory network a prime therapeutic target.
• Positive regulation of p53 signaling determines cell fate decisions such as arrest, repair, senescence, or apoptosis.
• Defects in this pathway contribute to chemoresistance and radioresistance in tumors.
• Neurodegenerative diseases often show altered p53 activity, linking this term to neuronal survival.
• Premature aging disorders such as Hutchinson-Gilford progeria syndrome involve p53 hyperactivation.
• The pathway is essential for the efficacy of many DNA-damaging chemotherapies.
• Understanding positive regulators can reveal biomarkers for cancer prognosis and treatment response.
• CRISPR-based models of this pathway enable functional validation of candidate regulators.
• The term is a key node in systems biology studies of DNA damage response networks.
• Drug discovery efforts targeting p53 regulators rely on accurate models of this process.
What Happens During positive regulation of DNA damage response, signal transduction by p53 class mediator?
DNA Damage Sensing and ATM/ATR Activation
In simple terms: When DNA is damaged, sensor proteins detect the damage and activate kinases that start the alarm.
DNA damage is detected by sensor complexes such as MRN (MRE11-RAD50-NBS1) and RPA, which recruit and activate the apical kinases ATM and ATR. ATM is primarily activated by double-strand breaks, while ATR responds to single-stranded DNA and replication stress. These kinases phosphorylate downstream effectors, including CHK1 and CHK2, to amplify the signal. Positive regulation of this step involves proteins that enhance ATM/ATR recruitment or activity, such as the MRN complex and TOPBP1.
p53 Stabilization and Phosphorylation
In simple terms: The p53 protein is normally kept at low levels; damage signals modify it so it accumulates and becomes active.
Under normal conditions, p53 is targeted for degradation by MDM2 and MDM4 ubiquitin ligases. DNA damage-induced phosphorylation of p53 at Ser15 and Ser20 by ATM/ATR and CHK1/CHK2 disrupts the p53-MDM2 interaction, leading to p53 stabilization. Positive regulators such as ARF inhibit MDM2, further promoting p53 accumulation. This step is a key checkpoint for p53 activation and is often dysregulated in cancer.
p53 Transcriptional Activation
In simple terms: Active p53 turns on a set of genes that decide the cell's fate.
Stabilized p53 binds to specific DNA response elements and activates transcription of target genes including CDKN1A (p21), MDM2, PUMA, and NOXA. These targets mediate cell cycle arrest, DNA repair, senescence, or apoptosis. Positive regulation of this step can occur through coactivators such as CBP/p300 and the Mediator complex, which enhance p53 transcriptional activity.
Feedback and Fine-Tuning
In simple terms: The pathway has built-in brakes and accelerators to keep the response balanced.
MDM2, a p53 target, provides a negative feedback loop by promoting p53 degradation. Positive regulators such as HAUSP (USP7) deubiquitinate and stabilize p53, while others like WIP1 (PPM1D) dephosphorylate and inactivate ATM/CHK2. The balance between positive and negative regulators determines the strength and duration of the p53 response.
Cell Fate Decision
In simple terms: Depending on the context, the p53 response can stop the cell cycle, repair damage, or trigger cell death.
The intensity and duration of p53 signaling, along with cofactors and tissue context, dictate whether cells undergo transient arrest, senescence, or apoptosis. Positive regulators of p53 can shift the balance toward tumor suppression or, when excessive, toward tissue degeneration. This decision point is critical for understanding diseases such as cancer and neurodegeneration.
Key Genes Involved in GO:0043517 positive regulation of DNA damage response, signal transduction by p53 class mediator
The following genes and proteins are central to the positive regulation of p53-mediated DNA damage response signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Tumor suppressor; transcription factor that mediates DNA damage response | Most frequently mutated gene in cancer; target for CRISPR knockout and knock-in models |
| ATM | Apical kinase activated by double-strand breaks; phosphorylates p53 and CHK2 | Mutations cause ataxia-telangiectasia; key positive regulator |
| ATR | Apical kinase activated by single-stranded DNA; phosphorylates CHK1 and p53 | Essential for replication stress response; target for cancer therapy |
| CHEK1 | Effector kinase downstream of ATR; phosphorylates p53 and CDC25 | Involved in cell cycle checkpoint control; potential drug target |
| CHEK2 | Effector kinase downstream of ATM; phosphorylates p53 and BRCA1 | Mutations associated with Li-Fraumeni-like syndrome |
| MDM2 | E3 ubiquitin ligase; negative regulator of p53 | Amplified in cancers; target for small molecule inhibitors |
| MDM4 | Negative regulator of p53; inhibits p53 transcriptional activity | Amplified in melanoma and other cancers |
| CDKN1A | p21; cyclin-dependent kinase inhibitor; mediates p53-induced cell cycle arrest | Biomarker of p53 activity; target for functional studies |
| BBC3 | PUMA; pro-apoptotic Bcl-2 family member; mediates p53-induced apoptosis | Key effector of p53-dependent cell death |
| PMAIP1 | NOXA; pro-apoptotic BH3-only protein; mediates p53-induced apoptosis | Involved in chemosensitivity |
| GADD45A | Growth arrest and DNA damage-inducible protein; involved in DNA repair | p53 target; marker of DNA damage response |
| RPS27L | Ribosomal protein; p53 target; involved in ribosomal stress response | Links p53 to ribosome biogenesis |
| HAUSP (USP7) | Deubiquitinase; stabilizes p53 and MDM2 | Positive regulator of p53; target for cancer therapy |
| PPM1D (WIP1) | Phosphatase; inactivates ATM, CHK1, CHK2, and p53 | Negative regulator; amplified in cancers |
| ARF (CDKN2A) | Inhibits MDM2; stabilizes p53 | Tumor suppressor; frequently deleted in cancer |
| TOPBP1 | Scaffold protein; activates ATR | Positive regulator of ATR signaling |
| RAD50 | Component of MRN complex; activates ATM | Mutations cause Nijmegen breakage syndrome-like disorder |
| NBN | Nibrin; component of MRN complex; activates ATM | Mutations cause Nijmegen breakage syndrome |
How Is positive regulation of DNA damage response, signal transduction by p53 class mediator Regulated?
The positive regulation of p53-mediated DNA damage response is tightly controlled by post-translational modifications, protein-protein interactions, and feedback loops. Kinases such as ATM, ATR, CHK1, and CHK2 phosphorylate p53 and its regulators to enhance signaling. Ubiquitin ligases (MDM2, MDM4) and deubiquitinases (HAUSP) modulate p53 stability. Phosphatases such as WIP1 provide negative feedback to reset the pathway. Additionally, ribosomal stress and oncogenic stress can activate p53 through ARF and ribosomal proteins, linking this term to broader cellular stress responses.
positive regulation of DNA damage response, signal transduction by p53 class mediator and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Li-Fraumeni syndrome; various cancers | CRISPR knockout and point mutation in cancer cell lines |
| ATM | Ataxia-telangiectasia | Knockout and knock-in models in neuronal and fibroblast cells |
| CHEK2 | Li-Fraumeni-like syndrome; breast cancer | Point mutation knock-in in mammary epithelial cells |
| MDM2 | Amplified in sarcomas and other cancers | Overexpression and knockout in cancer cell lines |
| PPM1D | Amplified in breast and ovarian cancers | Knockout and overexpression models |
Cancer
Dysregulation of GO:0043517 is a hallmark of cancer. TP53 mutations abrogate p53-mediated DNA damage responses, leading to genomic instability and tumor progression. Overexpression of MDM2 or MDM4, or loss of ARF, also inhibits p53 and promotes tumorigenesis. Conversely, excessive p53 activity can contribute to chemoresistance or normal tissue toxicity. Targeting positive regulators of p53 signaling is a major therapeutic strategy.
Neurodegeneration
Altered p53 activity has been implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's, where DNA damage and oxidative stress activate p53, leading to neuronal apoptosis. Positive regulators of p53 may exacerbate neuronal loss, making them potential targets for neuroprotection.
Premature Aging
Hyperactivation of p53 signaling is associated with premature aging syndromes, including Hutchinson-Gilford progeria syndrome and other laminopathies. In these conditions, chronic DNA damage and p53 activation contribute to tissue degeneration and aging phenotypes.
From positive regulation of DNA damage response, signal transduction by p53 class mediator-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene enhance or impair p53 activation? | CRISPR knockout cell line |
| Does a specific point mutation in TP53 affect its phosphorylation? | Point mutation knock-in cell line |
| Does a candidate regulator interact with p53 in vivo? | Tagged knock-in (e.g., GFP or HA) cell line |
| Does overexpression of a regulator drive p53-dependent apoptosis? | Overexpression cell line |
| Which genes are essential for p53-mediated DNA damage response? | CRISPR library screening |
| What are the transcriptomic changes upon p53 activation? | RNA-seq of knockout and wild-type cells |
How to Study the positive regulation of DNA damage response, signal transduction by p53 class mediator Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effects on p53 signaling | Identify positive regulators |
| CRISPR point mutation | Effect of specific amino acid changes on protein function | Dissect phosphorylation sites in p53 |
| CRISPR knock-in | Tagged or reporter protein expression | Live-cell imaging of p53 dynamics |
| Overexpression | Gain-of-function effects | Test if a gene is sufficient to activate p53 |
| RNA-seq | Transcriptional changes | Measure p53 target gene activation |
| Proteomics | Protein abundance and interactions | Identify p53 interactome |
| Imaging | Subcellular localization and dynamics | Monitor DNA damage foci and p53 nuclear translocation |
| Library screening | Genome-wide identification of regulators | Discover novel positive regulators |
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify positive regulators of p53 signaling. Cells are treated with DNA-damaging agents, and sgRNA enrichment or depletion is measured to pinpoint genes that modulate p53 activity. This approach is unbiased and scalable.
Transcriptomics and Proteomics
RNA-seq and mass spectrometry-based proteomics can quantify changes in p53 target gene expression and protein interactions upon DNA damage. These methods reveal the downstream effects of positive regulation.
Imaging and Reporter Assays
Fluorescent reporters of p53 activity, such as p53-GFP knock-in or luciferase-based reporters, allow real-time monitoring of p53 signaling in live cells. High-content imaging can assess cell cycle arrest, apoptosis, and DNA repair foci.
Functional Validation
After candidate regulators are identified, CRISPR knockout, point mutation, and rescue experiments are used to confirm causality. These models are essential for publication-grade mechanistic studies.
How CRISPR Can Be Used to Study GO:0043517 positive regulation of DNA damage response, signal transduction by p53 class mediator
Knockout
CRISPR knockout of candidate positive regulators (e.g., ATM, CHEK2) abolishes or reduces p53 activation upon DNA damage, demonstrating their essential role. Knockout cell lines are valuable for epistasis experiments and drug sensitivity assays.
Point Mutation
Introducing specific point mutations (e.g., TP53 Ser15Ala) via CRISPR knock-in allows precise dissection of phosphorylation-dependent regulation. These models reveal which residues are critical for p53 stabilization and function.
Knock-in
Tagged knock-in of p53 or its regulators (e.g., GFP, HA, or luciferase) enables real-time tracking of protein localization, stability, and interactions. This is particularly useful for studying dynamic positive regulation.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can test whether a candidate gene is sufficient to enhance p53 signaling. Overexpression models are useful for gain-of-function studies and drug target validation.
How EDITGENE Supports positive regulation of DNA damage response, signal transduction by p53 class mediator Research
Researchers studying positive regulation of DNA damage response, signal transduction by p53 class mediator-related genes often need to determine whether a candidate gene is causally involved in p53 activation, and to dissect the precise molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR-based services to generate publication-ready cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of DNA damage response, signal transduction by p53 class mediator research.
Frequently Asked Questions About positive regulation of DNA damage response, signal transduction by p53 class mediator
What is GO:0043517?
GO:0043517 is a Gene Ontology term for the biological process that positively regulates the p53-mediated DNA damage response signaling cascade.
What genes are involved in positive regulation of DNA damage response by p53?
Key genes include TP53, ATM, ATR, CHEK1, CHEK2, MDM2, MDM4, CDKN1A, and many others.
How is p53 activated by DNA damage?
DNA damage activates ATM/ATR kinases, which phosphorylate p53 and its regulators, leading to p53 stabilization and transcriptional activation.
What diseases are associated with dysregulation of this pathway?
Cancer, neurodegeneration, and premature aging syndromes are linked to altered p53 signaling.
What experimental models are used to study GO:0043517?
CRISPR knockout, point mutation, knock-in, overexpression cell lines, and library screens are commonly used.
How can I study positive regulators of p53 in my lab?
You can use CRISPR knockout or activation screens followed by validation with targeted models.
What is the role of MDM2 in p53 regulation?
MDM2 is an E3 ubiquitin ligase that negatively regulates p53 by promoting its degradation.
What is the difference between ATM and ATR in DNA damage response?
ATM primarily responds to double-strand breaks, while ATR responds to single-stranded DNA and replication stress.
Can CRISPR be used to create point mutations in TP53?
Yes, CRISPR knock-in can introduce precise point mutations to study p53 function.
What services does EDITGENE offer for p53 research?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services.
Conclusion
GO:0043517, positive regulation of DNA damage response, signal transduction by p53 class mediator, is a critical biological process that governs cellular responses to DNA damage. Its dysregulation is implicated in cancer, neurodegeneration, and aging. Advances in CRISPR-based models and high-throughput screening are accelerating the discovery of new regulators and therapeutic targets. EDITGENE provides the tools and expertise to study this pathway with precision and reproducibility.
References
- 1. Annanya A et al.. 2024. Computational Analysis of Single Nucleotide Polymorphisms in Human HIC1 Gene.. Cureus 16(3):e56664 PMID: 38646326
